Study of Lenvatinib in Patients With Advanced Cancer and Aberrations in FGF/FGFR Signaling
Clinical trial NCT02846766 · WITHDRAWN
Trial details
- NCT number
- NCT02846766
- Sponsor
- Teresa Helsten, MD
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-01
- Primary completion
- 2020-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.